ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P03303


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name POLG_HRV14
Primary accession number P03303
Secondary accession numbers Q82083 Q82123 Q84736 Q84737 Q84738 Q84739 Q84740 Q84741 Q84774 Q84775 Q84776 Q84777 Q84778 Q84779 Q89441 Q89649 Q89763 Q89883
Integrated into Swiss-Prot on July 21, 1986
Sequence was last modified on January 23, 2007 (Sequence version 3)
Annotations were last modified on    November 4, 2008 (Entry version 117)
Name and origin of the protein
Protein name Genome polyprotein
Synonyms None
Contains Protein VP0
     (VP4-VP2)
Protein VP4
     (Virion protein 4)
     (P1A)
Protein VP2
     (Virion protein 2)
     (P1B)
Protein VP3
     (Virion protein 3)
     (P1C)
Protein VP1
     (Virion protein 1)
     (P1D)
Picornain 2A
     (Protein 2A)
     (P2A)
     (EC 3.4.22.29)
Protein 2B
     (P2B)
Protein 2C
     (P2C)
     (EC 3.6.1.15)
Protein 3A
     (P3A)
Protein 3B
     (P3B)
     (VPg)
Picornain 3C
     (EC 3.4.22.28)
     (Protease 3C)
     (P3C)
RNA-directed RNA polymerase 3D-POL
     (P3D-POL)
     (EC 2.7.7.48)
Gene name None
From
Human rhinovirus 14 (HRV-14) [TaxID: 12131] 
Taxonomy Viruses; ssRNA positive-strand viruses, no DNA stage; Picornavirales; Picornaviridae; Rhinovirus.
Virus host Homo sapiens (Human) [TaxID: 9606]
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [GENOMIC RNA].
DOI=10.1093/nar/12.20.7859; PubMed=6093056 [NCBI, ExPASy, EBI, Israel, Japan]
Stanway G., Hughes P.J., Mountford R.C., Minor P.D., Almond J.W.;
"The complete nucleotide sequence of a common cold virus: human rhinovirus 14.";
Nucleic Acids Res. 12:7859-7875(1984).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC RNA].
PubMed=8383233 [NCBI, ExPASy, EBI, Israel, Japan]
Lee W.M., Monroe S., Rueckert R.R.;
"Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome.";
J. Virol. 67:2110-2122(1993).
[3]
NUCLEOTIDE SEQUENCE [GENOMIC RNA].
PubMed=2983312 [NCBI, ExPASy, EBI, Israel, Japan]
Callahan P.L., Mizutani S., Colonno R.J.;
"Molecular cloning and complete sequence determination of RNA genome of human rhinovirus type 14.";
Proc. Natl. Acad. Sci. U.S.A. 82:732-736(1985).
[4]
X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS).
DOI=10.1038/317145a0; PubMed=2993920 [NCBI, ExPASy, EBI, Israel, Japan]
Rossman M.G., Arnold E., Erickson J.W., Frankenberger E.A., Griffith J.P., Hecht H.-J., Johnson J.E., Kamer G., Luo M., Mosser A.G., Rueckert R.R., Sherry B., Vriend G.;
"Structure of a human common cold virus and functional relationship to other picornaviruses.";
Nature 317:145-153(1985).
[5]
X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS).
DOI=10.1107/S0108767387011875; PubMed=2856083 [NCBI, ExPASy, EBI, Israel, Japan]
Arnold E., Rossman M.G.;
"The use of molecular-replacement phases for the refinement of the human rhinovirus 14 structure.";
Acta Crystallogr. A 44:270-282(1988).
[6]
STRUCTURE BY ELECTRON MICROSCOPY (6.0 ANGSTROMS) OF 70-856 IN COMPLEX WITH ICAM1.
DOI=10.1093/emboj/18.22.6249; PubMed=10562537 [NCBI, ExPASy, EBI, Israel, Japan]
Kolatkar P.R., Bella J., Olson N.H., Bator C.M., Baker T.S., Rossmann M.G.;
"Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor.";
EMBO J. 18:6249-6259(1999).
[7]
X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS).
DOI=10.1016/0022-2836(90)90076-X; PubMed=2156077 [NCBI, ExPASy, EBI, Israel, Japan]
Arnold E., Rossman M.G.;
"Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3.0 A.";
J. Mol. Biol. 211:763-801(1990).
Comments
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
X01087; CAA25565.1; -; Genomic_RNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L05355; AAA45758.1; -; Genomic_RNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
K02121; AAA45756.1; -; Genomic_RNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
PIR A03901; GNNYH4.
3D structure databases
PDB
1D3I; EM; 26.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
1HRI; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
1HRV; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
1K5M; X-ray; 2.70 A; A=568-856, B=70-331, C=332-567, D=1-69.[ExPASy / RCSB / EBI]
1NA1; X-ray; 3.30 A; A=568-856, B=70-331, C=332-567, D=1-69.[ExPASy / RCSB / EBI]
1NCQ; X-ray; 2.50 A; A=568-856, B=70-331, C=332-567, D=1-69.[ExPASy / RCSB / EBI]
1R08; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
1R09; X-ray; 2.90 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
1RMU; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
1RUC; X-ray; 3.10 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
1RUD; X-ray; 2.90 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
1RUE; X-ray; 2.90 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
1RUF; X-ray; 2.90 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
1RUG; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
1RUH; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
1RUI; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
1RUJ; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
1RVF; X-ray; 4.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
1VRH; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
1XR5; X-ray; 2.80 A; A=1720-2179.[ExPASy / RCSB / EBI]
2B0F; NMR; -; A=1538-1719.[ExPASy / RCSB / EBI]
2HWB; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
2HWC; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
2IN2; NMR; -; A=1538-1719.[ExPASy / RCSB / EBI]
2R04; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
2R06; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
2R07; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
2RM2; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
2RMU; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
2RR1; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
2RS1; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
2RS3; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
2RS5; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
4RHV; X-ray; 3.00 A; 1=568-856, 2=70-331, 3=332-567, 4=1-69.[ExPASy / RCSB / EBI]
Detailed list of linked structures.
PDBsum 1D3I; -.
1HRI; -.
1HRV; -.
1K5M; -.
1NA1; -.
1NCQ; -.
1R08; -.
1R09; -.
1RMU; -.
1RUC; -.
1RUD; -.
1RUE; -.
1RUF; -.
1RUG; -.
1RUH; -.
1RUI; -.
1RUJ; -.
1RVF; -.
1VRH; -.
1XR5; -.
2B0F; -.
2HWB; -.
2HWC; -.
2IN2; -.
2R04; -.
2R06; -.
2R07; -.
2RM2; -.
2RMU; -.
2RR1; -.
2RS1; -.
2RS3; -.
2RS5; -.
4RHV; -.
ModBase P03303.
Protein family/group databases
MEROPS C03.013; -.
C03.020; -.
Ontologies
GO
GO:0031410; Cellular component: cytoplasmic vesicle (inferred from electronic annotation from UniProtKB-KW).
GO:0016020; Cellular component: membrane (inferred from electronic annotation from UniProtKB-KW).
GO:0044419; Biological process: interspecies interaction between organisms (inferred from electronic annotation from UniProtKB-KW).
QuickGo view.
Family and domain databases
InterPro IPR003593; AAA+_ATPase_core.
IPR004004; Helicase/Pol/Pept_Calicivir.
IPR000605; Helicase_SF3_ssDNA/RNA_vir.
IPR014759; Helicase_SF3_ssRNA_vir.
IPR014838; P3A.
IPR000199; Pept_C3_picorn.
IPR000081; Peptidase_C3.
IPR003138; Pico_P1A.
IPR002527; Pico_P2B.
IPR001676; Picornavirus_capsid.
IPR001205; RNA_pol_P3D.
IPR007094; RNA_pol_PSvir.
Graphical view of domain structure.
Pfam PF08727; P3A; 1.
PF00548; Peptidase_C3; 1.
PF02226; Pico_P1A; 1.
PF00947; Pico_P2A; 1.
PF01552; Pico_P2B; 1.
PF00680; RdRP_1; 1.
PF00073; Rhv; 3.
PF00910; RNA_helicase; 1.
Pfam graphical view of domain structure.
PRINTS PR00918; CALICVIRUSNS.
ProDom PD001125; Pept_C3_picorn; 1.
PD001306; Peptidase_C3_2; 1.
PD001274; Pico_P2B; 1.
[Domain structure / List of seq. sharing at least 1 domain]
SMART SM00382; AAA; 1.
SMART graphical view of domain structure.
PROSITE PS50507; RDRP_SSRNA_POS; 1.
PS51218; SF3_HELICASE_2; 1.
PROSITE graphical view of domain structure (profiles).
BLOCKS P03303.
ProtoNet P03303.
Other
LinkHub P03303; -.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
3D-structure; ATP-binding; Capsid protein; Complete proteome; Covalent protein-RNA linkage; Cytoplasm; Cytoplasmic vesicle; Helicase; Host-virus interaction; Hydrolase; Lipoprotein; Membrane; Myristate; Nucleotide-binding; Nucleotidyltransferase; Phosphoprotein; Protease; RNA replication; RNA-binding; RNA-directed RNA polymerase; Thiol protease; Transferase; Virion.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom    To Length Description FTId
INIT_MET   1      1        Removed; by host (By similarity). 
CHAIN   2    331  330     Protein VP0 (Potential). PRO_0000311074
CHAIN   2     69  68     Protein VP4 (Potential). PRO_0000040025
CHAIN   70    331  262     Protein VP2 (Potential). PRO_0000040026
CHAIN   332    567  236     Protein VP3 (Potential). PRO_0000040027
CHAIN   568    856  289     Protein VP1 (Potential). PRO_0000040028
CHAIN   857   1002  146     Picornain 2A (Potential). PRO_0000040029
CHAIN   1003   1099  97     Protein 2B (Potential). PRO_0000040030
CHAIN   1100   1429  330     Protein 2C (Potential). PRO_0000040031
CHAIN   1430   1514  85     Protein 3A (Potential). PRO_0000040032
CHAIN   1515   1537  23     Protein 3B (Potential). PRO_0000040033
CHAIN   1538   1719  182     Picornain 3C (Potential). PRO_0000040034
CHAIN   1720   2179  460     RNA-directed RNA polymerase 3D-POL (Potential). PRO_0000040035
TOPO_DOM   2   1491  1490     Cytoplasmic (Potential). 
TOPO_DOM   1492   1507  16     In membrane (Potential). 
TOPO_DOM   1508   2179  672     Cytoplasmic (Potential). 
DOMAIN   1205   1361  157     SF3 helicase. 
DOMAIN   1946   2060  115     RdRp catalytic. 
NP_BIND   1229   1236  8     ATP (Potential). 
ACT_SITE   876    876        For picornain 2A activity (By similarity). 
ACT_SITE   894    894        For picornain 2A activity (By similarity). 
ACT_SITE   965    965        For picornain 2A activity (By similarity). 
ACT_SITE   1577   1577        For picornain 3C activity (Potential). 
ACT_SITE   1608   1608        For picornain 3C activity (Potential). 
ACT_SITE   1683   1683        For picornain 3C activity (By similarity). 
SITE   69     70  2     Cleavage (Potential). 
SITE   331    332  2     Cleavage; by picornain 3C (Potential). 
SITE   856    857  2     Cleavage; by picornain 2A (Potential). 
SITE   1002   1003  2     Cleavage; by picornain 3C (Potential). 
SITE   1099   1100  2     Cleavage; by picornain 3C (Potential). 
SITE   1429   1430  2     Cleavage; by picornain 3C (Potential). 
SITE   1514   1515  2     Cleavage; by picornain 3C (Potential). 
SITE   1537   1538  2     Cleavage; by picornain 3C (Potential). 
SITE   1719   1720  2     Cleavage; by picornain 3C (Potential). 
MOD_RES   1517   1517        O-(5'-phospho-RNA)-tyrosine (By similarity). 
LIPID   2      2        N-myristoyl glycine; by host (By similarity). 
CONFLICT   368    368        P -> L (in Ref. 3; AAA45756). 
CONFLICT   459    459        I -> T (in Ref. 3; AAA45756). 
CONFLICT   722    722        P -> H (in Ref. 3; AAA45756). 
CONFLICT   726    727        NP -> KS (in Ref. 3). 
CONFLICT   729    731        EWD -> RVG (in Ref. 3). 
CONFLICT   913    913        C -> R (in Ref. 3; AAA45756). 
CONFLICT   942    942        N -> S (in Ref. 3; AAA45756). 
CONFLICT   962    962        P -> L (in Ref. 3; AAA45756). 
CONFLICT   982    982        G -> E (in Ref. 3; AAA45756). 
CONFLICT   1193   1193        L -> F (in Ref. 3; AAA45756). 
CONFLICT   1193   1193        L -> H (in Ref. 2; AAA45758). 
CONFLICT   1220   1220        I -> T (in Ref. 2 and 3). 
CONFLICT   1399   1399        I -> V (in Ref. 2 and 3). 
CONFLICT   1446   1446        P -> S (in Ref. 3; AAA45756).